• Latest Posts

Drug for Autoimmune Liver Disease Yields Mixed Results in Hard-to-Treat Patients

Solid Phase II Performance for French Autoimmune Liver Disease Drug

This French Biotech is Starting Two New Trials to Treat Kidney and Liver Fibrosis

In Geneva, the Capital of Peace, 10 Biotechs Are Putting up a Fight

French Biotech gets a Second Opportunity to Fight Liver Fibrosis


Genkyotex’ NOX inhibitor candidate Fails to follow through on Phase II